Does the Syrian population have to wait for the new generation of human papillomaviruses vaccine?

Does the Syrian population have to wait for the new generation of human papillomaviruses vaccine?
复制标题

DOI:
10.4161/hv.21973
复制
发表时间:
2012-12-01
影响因子:
4.8
通讯作者:
Akil, Nizar
Akil, Nizar
中科院分区:
医学3区
文献类型:
--
作者:
Al Moustafa, Ala-Eddin;Yasmeen, Amber;Akil, Nizar

文献摘要

被引文献

相似文献

我们最近进行了几项关于叙利亚人宫颈癌、结直肠癌和乳腺癌中高危hpv存在的研究。在此,我们报告高危型hpv 16、18、33、45、51、52和58在该人群的结直肠癌中经常出现。因此,根据以前的研究和目前的数据,我们得出结论,叙利亚人口中最常见的高危HPV类型是16、18、33、35、45、51、52和58。因此,我们的数据表明,使用新一代HPV疫苗保护叙利亚人口免受高危HPV及其相关癌症的侵害将是有用的。
We recently conducted several studies regarding the presence of high-risk HPVs in human cervical, colorectal and breast cancers in the Syrian population. Herein, we report that high-risk HPVs type 16, 18, 33, 45, 51, 52 and 58 are frequently present in colorectal cancer in this population. Therefore and based on previous studies and present data, we conclude that the most frequent high-risk HPV types, in the Syrian population, are 16, 18, 33, 35, 45, 51, 52 and 58. Thus, our data suggest that it will be useful to use the new generation of HPV vaccine to protect the Syrian population from high-risk HPVs and their associated cancers.